Dexcom falls after warning stolen glucose sensors sold to patients
BUZZ-Dexcom falls after warning stolen glucose sensors sold to patients ** Shares of medical device maker Dexcom DXCM.O slipped 2.3% to $70.43, snapping a six-day gaining streak
** The firm says some of its glucose sensors meant for disposal were stolen and sold by third parties
** Dexcom warns patients not to use sensors from the affected batches and to seek replacements
** Some of the stolen sensors may cause skin infections or fail to give readings - Dexcom
** Adds that it is working with regulators to investigate and says no serious harm is reported
** The issue involves Dexcom's G7 continuous glucose monitoring sensors
** As of last close, stock up 8.6% YTD
(Reporting by Kamal Choudhury in Bengaluru)
Recent news on DexCom
See all newsU.S. RESEARCH ROUNDUP-Ferrari, Hawkeye 360, Micron Technology
FDA clears first over-the-counter glucose monitor for children
Brief: FDA Clears For Marketing Dexcom's Stelo Glucose Biosensor System For Children
Pharmsource says it was unaware Dexcom sensors it bought were slated for destruction
U.S. RESEARCH ROUNDUP- Apple, Lennar, Toll Brothers